Cancer Policy Federal judge rules Trump directives canceling NIH grants “illegal,” orders them to be restored June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy NIH Director Jay Bhattacharya launches a podcast June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy FDA to issue “national priority vouchers” to companies supporting U.S. interests June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy Vinay Prasad named chief medical and scientific officer at FDA June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy FDA halts new clinical trials that export Americans’ cells to foreign labs in hostile countries June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy In “Bethesda Declaration,” NIH employees, Nobel laureates say Bhattacharya is favoring politics over U.S. science, health June 13, 2025Vol.51 No.23By Jacquelyn Cobb
Cancer Policy AMA President Bobby Mukkamala, brain cancer survivor, says NIH research saved his life June 13, 2025Vol.51 No.23By Jacquelyn Cobb
Cancer Policy Kennedy: “We’re going to end the war at FDA against alternative medicine” June 13, 2025Vol.51 No.23By Jacquelyn Cobb
Cancer Policy George Sigounas named the first-ever chief science advisor at NCI June 06, 2025Vol.51 No.22By Paul Goldberg
Cancer Policy Success rates for RPGs at NCI would plummet from 13.4% to 8.3% if Trump’s FY2026 budget is enacted June 06, 2025Vol.51 No.22By Paul Goldberg
